What The Study Did: Researchers investigated changes in buprenorphine prescribing, a treatment for opioid use disorder, to Medicaid beneficiaries during the first year of the COVID-19 pandemic.
Authors: William N. Dowd, B.A., of RTI International in Research Triangle Park, North Carolina, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.4058)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.4058?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032422
JAMA Network Open